{
     "PMID": "24903161",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141126",
     "LR": "20140930",
     "IS": "1535-3699 (Electronic) 1535-3699 (Linking)",
     "VI": "239",
     "IP": "10",
     "DP": "2014 Oct",
     "TI": "Vitamin B6 prevents cognitive impairment in experimental pneumococcal meningitis.",
     "PG": "1360-5",
     "LID": "10.1177/1535370214535896 [doi]",
     "AB": "Streptococcus pneumoniae is the relevant cause of bacterial meningitis, with a high-mortality rate and long-term neurological sequelae, affecting up to 50% of survivors. Pneumococcal compounds are pro-inflammatory mediators that induce an innate immune response and tryptophan degradation through the kynurenine pathway. Vitamin B6 acts as a cofactor at the active sites of enzymes that catalyze a great number of reactions involved in the metabolism of tryptophan, preventing the accumulation of neurotoxic intermediates. In the present study, we evaluated the effects of vitamin B6 on memory and on brain-derived neurotrophic factor (BDNF) expression in the brain of adult Wistar rats subjected to pneumococcal meningitis. The animals received either 10 microL of artificial cerebral spinal fluid (CSF) or an equivalent volume of S. pneumoniae suspension. The animals were divided into four groups: control, control treated with vitamin B6, meningitis, and meningitis treated with vitamin B6. Ten days after induction, the animals were subjected to behavioral tests: open-field task and step-down inhibitory avoidance task. In the open-field task, there was a significant reduction in both crossing and rearing in the control group, control/B6 group, and meningitis/B6 group compared with the training session, demonstrating habituation memory. However, the meningitis group showed no difference in motor and exploratory activity between training and test sessions, demonstrating memory impairment. In the step-down inhibitory avoidance task, there was a difference between training and test sessions in the control group, control/B6 group, and meningitis/B6 group, demonstrating aversive memory. In the meningitis group, there was no difference between training and test sessions, demonstrating impairment of aversive memory. In the hippocampus, BDNF expression decreased in the meningitis group when compared to the control group; however, adjuvant treatment with vitamin B6 increased BDNF expression in the meningitis group. Thus, vitamin B6 attenuated the memory impairment in animals subjected to pneumococcal meningitis.",
     "CI": [
          "(c) 2014 by the Society for Experimental Biology and Medicine."
     ],
     "FAU": [
          "Barichello, Tatiana",
          "Generoso, Jaqueline S",
          "Simoes, Lutiana R",
          "Ceretta, Renan A",
          "Dominguini, Diogo",
          "Ferrari, Pamela",
          "Gubert, Carolina",
          "Jornada, Luciano K",
          "Budni, Josiane",
          "Kapczinski, Flavio",
          "Quevedo, Joao"
     ],
     "AU": [
          "Barichello T",
          "Generoso JS",
          "Simoes LR",
          "Ceretta RA",
          "Dominguini D",
          "Ferrari P",
          "Gubert C",
          "Jornada LK",
          "Budni J",
          "Kapczinski F",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Microbiologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, 77030, Houston, TX, USA tba@unesc.net. Laboratorio de Microbiologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Laboratorio de Microbiologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Laboratorio de Microbiologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Laboratorio de Psiquiatria Molecular, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 90035003, Porto Alegre, RS, Brasil. Laboratorio de Psiquiatria Molecular, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 90035003, Porto Alegre, RS, Brasil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Laboratorio de Neurodegeneracao, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil. Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, 77030, Houston, TX, USA Laboratorio de Psiquiatria Molecular, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 90035003, Porto Alegre, RS, Brasil. Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, 77030, Houston, TX, USA Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 888806-000, Criciuma, SC, Brasil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140605",
     "PL": "England",
     "TA": "Exp Biol Med (Maywood)",
     "JT": "Experimental biology and medicine (Maywood, N.J.)",
     "JID": "100973463",
     "RN": [
          "0 (Brain-Derived Neurotrophic Factor)",
          "0 (Vitamins)",
          "8059-24-3 (Vitamin B 6)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain-Derived Neurotrophic Factor/biosynthesis",
          "Cognition Disorders/*prevention & control",
          "Gene Expression Profiling",
          "Hippocampus/pathology",
          "Humans",
          "Male",
          "Memory",
          "Meningitis, Pneumococcal/*complications",
          "Rats, Wistar",
          "Vitamin B 6/*administration & dosage",
          "Vitamins/*administration & dosage"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "BDNF",
          "Pneumococcal meningitis",
          "memory",
          "vitamin B6"
     ],
     "EDAT": "2014/06/07 06:00",
     "MHDA": "2014/12/15 06:00",
     "CRDT": [
          "2014/06/07 06:00"
     ],
     "PHST": [
          "2014/06/07 06:00 [entrez]",
          "2014/06/07 06:00 [pubmed]",
          "2014/12/15 06:00 [medline]"
     ],
     "AID": [
          "1535370214535896 [pii]",
          "10.1177/1535370214535896 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Exp Biol Med (Maywood). 2014 Oct;239(10):1360-5. doi: 10.1177/1535370214535896. Epub 2014 Jun 5.",
     "term": "hippocampus"
}